Entry into or termination of material definitive agreements (Items 1.01/1.02).
NextTrip, Inc. entered into Registration Rights Agreement with the Purchaser.
“Pursuant to a Registration Rights Agreement between the Company and the Purchaser (the “Registration Rights Agreement”), the Company has agreed to file a registration statement (the “Resale Registration Statement”) to cover the resale of the Common Shares and any share of Common Stock underlying the Warrants”
NextTrip, Inc. entered into Placement Agreement with Ladenburg Thalmann & Co. Inc. (effective 2025-12-22).
“Pursuant to a Placement Agency Agreement dated as of December 22, 2025 (the “Placement Agreement”), the Company engaged Ladenburg Thalmann & Co. Inc. (the “Placement Agent”) to act as the Company’s exclusive placement agent in connection with the Offering.”
NextTrip, Inc. entered into Purchase Agreement with a purchaser named therein (the “Purchaser”) valued at approximately $3,000,000 (effective 2025-12-22).
“On December 22, 2025, NextTrip, Inc., a Nevada corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a purchaser named therein (the “Purchaser”), pursuant to which the Company agreed to issue and sell, in a private placement (the “Offering”) 1,000,000 shares (the “Common Shares”) of the Company’s Common Stock”
CIRTRAN CORP entered into Standby Equity Purchase Agreement with YA II PN, Ltd. valued at $10,000,000 (effective 2025-12-22).
“On December 22, 2025, we entered into a Standby Equity Purchase Agreement (the “Purchase Agreement”) with YA II PN, Ltd., a Cayman Islands exempt limited partnership(“YA”). Under the Purchase Agreement, we have the right to sell to YA up to $10,000,000 of shares of our common stock, subject to certain limitations and conditions set forth in the Purchase Agreement, from time to time during the term of the Purchase Agreement.”
AAON, INC. amended Sixth Amendment with BOKF, NA dba Bank of Oklahoma, Wells Fargo Bank, National Association, Bank of America, National Association, U.S. Bank, National Association and Associated Bank, National Association valued at $600.0 million (effective 2025-12-29).
“On December 29, 2025 (the “Effective Date”), AAON, Inc., an Oklahoma corporation, AAON Coil Products, Inc., a Texas corporation, and BASX, Inc., an Oregon corporation, all wholly-owned subsidiaries of AAON, Inc., a Nevada Corporation (collectively, the "Company"), executed the Sixth Amendment (the "Amendment") to the Amended and Restated Loan Agreement (collectively, as amended, the "Amended Loan Agreement") with the following lenders: BOKF, NA dba Bank of Oklahoma, Wells Fargo Bank, National Association, Bank of America, National Association, U.S. Bank, National Association and Associated Bank, National Association (collectively, the "Lenders") with BOKF, NA as the administrative agent for the Lenders.”
QHSLab, Inc. entered into Subscription Agreements with two accredited investors valued at approximately $500,000 (effective 2025-12-26).
“On December 26, 2025, QHSLab, Inc. (the “Company”) accepted subscription agreements from two accredited investors for the purchase of approximately $500,000 of the Company’s common stock and warrants”
Capstone Holding Corp. entered into Nectarine Letter Agreement with Nectarine Management LLC.
“o vote on a proposal to approve possible future payments to Nectarine Management LLC (“Nectarine”). Nectarine is owned by Michael Toporek, Matthew E.”
Algorhythm Holdings, Inc. entered into Secured Pre-Paid Purchase #3 with Streeterville Capital, LLC valued at $1,090,000 (effective 2025-12-19).
“On December 19, 2025, Algorhythm Holdings, Inc. (the “Company”) entered into Secured Pre-Paid Purchase #3 with Streeterville Capital, LLC, a Utah limited liability company (“Streeterville”)”
Azenta, Inc. entered into Share Purchase Agreement with Thelema S.À R.L. valued at USD 63,000,000 (effective 2025-12-23).
“On December 23, 2025, Azenta Germany GmbH, a wholly owned subsidiary of Azenta, Inc. (“Azenta” or the “Company”) entered into a definitive Sale and Purchase Agreement (“Share Purchase Agreement”) with Thelema S.À R.L. (“Thelema”) relating to the entire issued share capital of B Medical Systems S.À R.L. (“B Medical”), a subsidiary of Azenta Germany GmbH.”
HENRY SCHEIN INC amended Private Shelf Amendments with PGIM, Inc.; NYL Investors LLC; Metropolitan Life Insurance Company; Corebridge Institutional Investors (U.S.), LLC (effective 2025-12-19).
“On December 19, 2025, Henry Schein, Inc. (the “ Company ”) amended its (i) Third Amended and Restated Private Shelf Agreement, dated as of October 20, 2021, by and among the Company, PGIM, Inc. (“ Prudential ”) and each Prudential affiliate party thereto, (ii) Third Amended and Restated Master Note Facility, dated as of October 20, 2021, by and among the Company, NYL Investors LLC (as successor in interest to New York Life Investment Management LLC) (“ New York Life ”) and each New York Life affiliate party thereto, (iii) Third Amended and Restated Master Note Purchase Agreement, dated as of October 20, 2021, by and among the Company, Metropolitan Life Insurance Company (“ MLIC ”), MetLife Investment Management, LLC (as successor in interest to MetLife Investment Advisors Company, LLC) (“ MLIAC ,” and together with MLIC, “ MetLife ”) and each MetLife affiliate party thereto, and (iv) Multicurrency Private Shelf Agreement, dated as of October 20, 2021, by and among the Company, Corebrid”
WILLIS LEASE FINANCE CORP entered into Servicing Agreement with Willis Lease Finance Corporation (effective 2025-12-23).
“Servicing Agreement dated as of December 23, 2025 among WEST and Willis, as servicer and administrative agent, providing for the appointment of Willis as the servicer of the assets of WEST and its subsidiaries.”
WILLIS LEASE FINANCE CORP entered into Asset Purchase Agreement with Willis Lease Finance Corporation (effective 2025-12-23).
“Asset Purchase Agreement dated as of December 23, 2025 by and between Willis, as seller, and WEST, as purchaser, providing for, among other things, the sale by Willis to WEST of 47 aircraft engines and two airframes during a specified delivery period, by way of direct sale of the assets or the sale of beneficial ownership interests in trusts that own the assets.”
WILLIS LEASE FINANCE CORP entered into Trust Indenture with U.S. Bank National Association, Bank of America, N.A. valued at $392,900,000 in aggregate principal amount (effective 2025-12-23).
“On December 23, 2025, Willis Lease Finance Corporation (the “Company”) and its direct, wholly-owned subsidiary Willis Engine Structured Trust IX (“WEST”), closed its offering of $392,900,000 in aggregate principal amount of fixed rate notes (the “Notes”).”
STEEL DYNAMICS INC terminated Indenture dated December 6, 2016 for 5.000% Senior Notes due 2026 with Computershare Trust Company, N.A. valued at Principal amount $400,000,000 redeemed at 100.000% plus accrued interest (effective 2025-12-21).
“Item 1.02. Termination of a Material Definitive Agreement. Effective December 21, 2025, Steel Dynamics, Inc. (the “Company”) redeemed and subsequently repaid all of its outstanding 5.000% Senior Notes due 2026 (the “Notes”) at a price of 100.000% of the principal amount of $400,000,000, together with accrued and unpaid interest to, but not including, December 21, 2025. The Notes were issued in the original principal amount of $400,000,000, pursuant to an Indenture, as amended and supplemented, dated as of December 6, 2016 (the “Indenture”), between the Company, as Issuer, and Computershare Trust Company, N.A., as successor to Wells Fargo Bank, National Association, as Trustee. Pursuant to Section 8.01 of the Indenture, the Company having fully paid all remaining sums payable thereunder, and having delivered all Notes to the Trustee for cancellation, the Company’s obligations under the Indenture have now been terminated.”
HERITAGE COMMERCE CORP entered into Agreement and Plan of Reorganization and Merger with CVB Financial Corp. (effective 2025-12-17).
“On December 17, 2025, Heritage Commerce Corp, a California corporation (the “Company”) and CVB Financial Corp., a California corporation (“CVBF”) entered into an Agreement and Plan of Reorganization and Merger (the “Reorganization Agreement”), pursuant to which the Company will merge with and into CVBF, with CVBF as the surviving corporation (the “Merger”).”
Alaunos Therapeutics, Inc. entered into Settlement and Release Agreement with The University of Texas M.D. Anderson Cancer Center valued at $285,055 (effective 2025-12-17).
“On December 17, 2025, Alaunos Therapeutics, Inc. (the “Company”) entered into a Settlement and Release Agreement (the “Settlement Agreement”) with The University of Texas M.D. Anderson Cancer Center (“MD Anderson”) resolving all disputes related to unpaid invoices under the 2019 Research and Development Agreement.”
CapForce Inc. amended Supplemental Letter to the Purchase Agreement with AEI Capital Ltd. valued at extended ability to sell shares until December 31, 2026 (effective 2025-12-17).
“On December 17, 2025, the Company and the Purchaser entered into a Supplemental Letter to the Purchase Agreement (the “Supplemental Letter”), which amended the Purchase Agreement by extending the Company’s ability to sell shares of common stock to the Purchaser until December 31, 2026.”
LIXTE BIOTECHNOLOGY HOLDINGS, INC. entered into Collaborative Research Agreement with The University of Texas M.D. Anderson Cancer Center (effective 2025-12-17).
“On December 17, the Company entered into a Collaborative Research Agreement with the Anderson Cancer Center (the “Research Agreement”).”
LIXTE BIOTECHNOLOGY HOLDINGS, INC. amended Amendment No.2 with GlaxoSmithKline LLC and The University of Texas M.D. Anderson Cancer Center (effective 2025-12-17).
“On December 17, 2025, Lixte Biotechnology Holdings, Inc., a Delaware corporation (the “Company”), entered into Amendment No.2 (“Amendment No.2”) to the GSK & LIXTE Supported Collaborative Study (the “Collaborative Study”) by and between the Company, GlaxoSmithKline LLC (“GSK”) and the University of Texas M.D. Anderson Cancer Center”
AeroVironment Inc entered into Lease with QOZ 201CC TWO, LLC (effective 2025-12-18).
“On December 18, 2025, AeroVironment, Inc. (the “Company”) executed a new lease (the “Lease”) with QOZ 201CC TWO, LLC (the “Landlord”)”
CDW Corp entered into New Loan Agreement with JPMorgan Chase Bank, N.A., as administrative agent, Wells Fargo Commercial Distribution Finance, LLC, as floorplan funding agent, and the joint lead arrangers, joint bookrunners, co-syndication agents, and co-documentation agents party thereto valued at $2,884.5 million (effective 2025-12-17).
“On December 17, 2025 (the “Effective Date”), CDW LLC, an Illinois limited liability company (“CDW”), entered into a new five-year $2,884.5 million senior unsecured credit facility (the “Senior Credit Facility”), consisting of (a) a term loan facility in the amount of $634.5 million, fully funded on the Effective Date, and (b) a revolving loan facility in the amount of $2,250.0 million, with a letter of credit subfacility of $175,000,000 and a swingline subfacility of $100,000,000 thereunder . The terms of the Senior Credit Facility are set forth in the Credit Agreement, dated as of December 17, 2025, by and among CDW, CDW Finance Holdings Limited, a private limited company incorporated under the laws of England and Wales with company number 05872067 (the “UK Borrower”), the guarantors party thereto, the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, Wells Fargo Commercial Distribution Finance, LLC (“Wells Fargo CDF”), as floorplan funding agent, and the join”
FS KKR Capital Corp entered into Indenture and Credit Agreements (for CLO Transaction) with KKR - FSK CLO 3 LLC valued at $389,500,000 (effective 2025-12-18).
“On December 18, 2025 (the “ Closing Date ”), KKR - FSK CLO 3 LLC (the “ Issuer ”), a Delaware limited liability company and a wholly owned and consolidated special purpose financing subsidiary of FS KKR Capital Corp. (the “ Company ”), completed a $389,500,000 term debt securitization (the “ CLO Transaction ”).”
CEMTREX INC entered into Securities Purchase Agreement with a single accredited institutional investor valued at aggregate gross proceeds of $2,000,000 (effective 2025-12-23).
“On December 23, 2025, Cemtrex, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a single accredited institutional investor (the “Purchaser”), pursuant to which the Company agreed to issue and sell to the Purchaser, in a registered direct offering (the “Offering”), securities consisting of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and/or pre-funded warrants to purchase shares of Common Stock (the “Pre-Funded Warrants”), for aggregate gross proceeds of $2,000,000.”
IRONWOOD PHARMACEUTICALS INC amended Third Amendment to Amended and Restated Exclusive License Agreement with Ferring International Center S.A. valued at $12.5 million aggregate payment to Ferring, including an initial payment of $7.5 million and a secon (effective 2025-12-18).
“On December 18, 2025, Ironwood Pharmaceuticals, Inc. (the "Company"), solely for purposes of a limited payment guarantee, VectivBio AG, a wholly owned subsidiary of the Company ("VectivBio"), and Ferring International Center S.A. ("Ferring"), entered into that certain third amendment (the "Amendment") to the amended and restated exclusive license agreement, dated as of December 6, 2016, as amended, by and between GlyPharma Therapeutic Inc. (as predecessor to VectivBio) and Ferring (the "Ferring License Agreement").”
Skye Bioscience, Inc. entered into Non-exclusive Collaboration and License Agreement with Halozyme, Inc. valued at milestone payments tied to achievement of certain development and commercialization milestone events (effective 2025-12-18).
“On December 18, 2025, Skye Bioscience, Inc. (the “Company”) entered into a Non-exclusive Collaboration and License Agreement (the “Agreement”) with Halozyme, Inc. (“Halozyme”).”
Starco Brands, Inc. entered into Promissory Note with The Starco Group, Inc. valued at $5,000,000 (effective 2025-12-22).
“On December 22, 2025, (i) Starco Brands, Inc., a Nevada corporation (“ Starco ” or the “ Company ”) entered into a Bridge Term Loan Promissory Note (the “ Promissory Note ”) with The Starco Group, Inc., a Wyoming corporation (“ Lender ”). The Promissory Note provides for a bridge term loan in the principal amount of up to $5,000,000”
Taylor Morrison Home Corp entered into Credit Agreement with lenders and Wells Fargo Bank, National Association valued at $1,000,000,000 (effective 2025-12-22).
“On December 22, 2025 (the “Closing Date”), Taylor Morrison Communities, Inc. (the “Borrower”), a wholly owned subsidiary of Taylor Morrison Home Corporation (“Taylor Morrison” or the “Company”), entered into the Amendment and Restatement Agreement (the “Amendment”) to the Amended and Restated Credit Agreement dated as of March 11, 2022 (as amended, restated, supplemented or otherwise modified prior to the Amendment, the “Existing Credit Agreement” and as further amended and restated by the Amendment, the “Credit Agreement”)”
ADM ENDEAVORS, INC. entered into Equity Financing Agreement with GHS Investments LLC valued at up to $20,000,000 (effective 2025-12-19).
“On December 19, 2025, ADM Endeavors, Inc. (the “ Company ”) entered into an equity financing agreement (the “ Equity Financing Agreement ”) with GHS Investments LLC (“ GHS ”), pursuant to which GHS will purchase up to $20,000,000 of Company common stock”
AB Private Credit Investors Corp amended Credit Agreement with Natixis, New York Branch (effective 2025-12-18).
“On December 18, 2025, ABPCI Funding II LLC, formerly known as ABPCIC Funding IV LLC (the “ Borrower ”), a wholly-owned subsidiary of AB Private Credit Investors Corporation (the “ Fund ”), amended and restated the credit agreement establishing its revolving credit facility (the “ Credit Facility ”) with Natixis, New York Branch, as administrative agent, the lenders and each of the other parties thereto.”
AMERICAN REBEL HOLDINGS INC entered into Boot Note with Boot Capital LLC valued at $86,250 (effective 2025-12-15).
“On December 15, 2025, the Company entered into a Securities Purchase Agreement with Boot Capital LLC, an accredited investor (“Boot”), pursuant to which Boot made a loan to the Company, evidenced by a promissory note in the principal amount of $86,250 (the “Boot Note”).”
AMERICAN REBEL HOLDINGS INC entered into 1800 Note with 1800 Diagonal Lending, LLC valued at $152,950 (effective 2025-12-15).
“On December 15, 2025, the Company entered into a Securities Purchase Agreement with 1800 Diagonal Lending, LLC, an accredited investor (“1800”), pursuant to which 1800 made a loan to the Company, evidenced by a promissory note in the principal amount of $152,950 (the “1800 Note”).”
BEYOND MEAT, INC. entered into Side Letter Agreement with Unprocessed Foods, LLC valued at adjustment of warrant strike price from $3.26 to $1.95 (effective 2025-12-22).
“The Company has agreed pursuant to a side letter agreement with Unprocessed Foods dated as of December 22, 2025 (the “Side Letter Agreement”) that the strike price for the Warrants will be adjusted from $3.26 to $1.95 in order to fully account for any and all potential past or future adjustments relating to the previously reported exchange of its 0% Convertible Senior Notes due 2027 for $209,721,000 in principal amount of New Convertible Notes and 317,834,446 shares of common stock that was completed on October 30, 2025, the payment of interest on the New Convertible Notes in the form of common stock or in the form of payment-in-kind interest, as well as certain mandatory conversions, equitizations and make-whole payments that could result in additional issuances of common stock thereunder, if any.”
BEYOND MEAT, INC. entered into Intercreditor Agreement Amendment with Unprocessed Foods, LLC; Wilmington Trust, National Association valued at amendment to permit exchanges of Second Lien Obligations for shares of common stock (effective 2025-12-22).
“On December 22, 2025, the parties to the Intercreditor Agreement entered into an amendment to the Intercreditor Agreement (the “Intercreditor Agreement Amendment”) to, among other things, permit the Company to enter into exchanges of its Second Lien Obligations (as defined in the Intercreditor Agreement) for shares of the Company’s common stock.”
Bloom Energy Corp entered into Credit Agreement with Wells Fargo Bank, National Association, as administrative agent and collateral agent, the letter of credit issuer party thereto, and the financial institutions party thereto as lenders valued at $600 million (effective 2025-12-19).
“On December 19, 2025, Bloom Energy Corporation (the “Company”) entered into a Credit Agreement (the “Credit Agreement”) with Wells Fargo Bank, National Association, as administrative agent and collateral agent, the letter of credit issuer party thereto, and the financial institutions party thereto as lenders.”
JUPITER NEUROSCIENCES, INC. entered into SEPA with Yorkville.
“he SEPA, Yorkville represented to the Company, among other things, that it is an “accredited investor” (as such term is defined in Rule 501(a) of Regulation D under the Securities Act).”
Inmune Bio, Inc. amended Warrant Amendment with certain holders of warrants previously issued by the Company valued at $0.05 per April 2024 Warrant, for aggregate proceeds of $67,416 (effective 2025-12-22).
“On December 22, 2025, INmune Bio Inc. (the “Company”) entered into an amendment (the “Warrant Amendment”) with certain holders of warrants previously issued by the Company in its April 2024 offerings”
Camp4 Therapeutics Corp terminated Cambridge Lease with ARE-MA Region No. 59, LLC valued at termination date accelerated to 30 days after Watertown Lease Commencement Date (effective 2025-12-22).
“The Lease Amendment will accelerate the termination date of the Cambridge Lease to the date (the “Early Termination Date”) thirty days after the Commencement Date of the Watertown Lease (as such terms are defined below).”
Camp4 Therapeutics Corp amended First Amendment to Lease Agreement with ARE-MA Region No. 59, LLC valued at accelerates termination date to 30 days after Watertown Lease Commencement Date; base rent abated fr (effective 2025-12-22).
“On December 22, 2025 (the “Effective Date”), CAMP4 Therapeutics Corporation (the “Company”) and ARE-MA Region No. 59, LLC (“ARE 59”) entered into the First Amendment (the “Lease Amendment”) to the Lease Agreement (the “Cambridge Lease”), dated October 3, 2019, by and between the Company and ARE 59.”
Camp4 Therapeutics Corp entered into Lease Agreement with ARE-MA Region No. 75, LLC valued at annual base rent $40.00 per rentable square foot, subject to annual increases of 3%; initial term en (effective 2025-12-22).
“Also on the Effective Date, the Company entered into a Lease Agreement (the “Watertown Lease”) with ARE-MA Region No. 75, LLC (“ARE 75”), an affiliate of ARE 59, for approximately 44,000 rentable square feet of laboratory and office space located at 100 Talcott Avenue, Watertown, Massachusetts (the “Watertown Premises”).”
Celularity Inc entered into Convertible Note Purchase Agreement with accredited investor valued at Senior secured convertible promissory note in the principal amount of $3,000,000 and a warrant to pu (effective 2025-12-19).
“On the Effective Date, the Company also entered into a Convertible Note Purchase Agreement (the “Convertible Note Securities Purchase Agreement”), with the Investor pursuant to which the Company issued the Investor a senior secured convertible promissory note in the principal amount of $3,000,000 (the “Convertible Note” and together with the Senior Note, the “Notes”) and a warrant to purchase up to 1,258,740 shares of the Company’s Class A common stock (the “Convertible Note Warrant”).”
Celularity Inc entered into Senior Securities Purchase Agreement with accredited investor valued at Senior Secured Non-Convertible Promissory Note in the principal amount of $7,000,000 and a warrant t (effective 2025-12-19).
“On December 19, 2025 (the “Effective Date”), Celularity Inc. (the “Company”) entered into a series of agreements relating to (i) a senior secured note financing (the “Senior Secured Note Financing”) and (ii) a convertible note financing (the “Convertible Note Financing” and together with the Senior Secured Note Financing, the “Financings”) with an accredited investor (the “Investor”).”
Osprey Bitcoin Trust amended Third Amended and Restated Declaration of Trust and Trust Agreement with CSC Delaware Trust Company valued at Amended trust agreement to effectuate conversion of trust into an exchange-traded product and listin (effective 2025-12-18).
“On December 18, 2025, Osprey Funds, LLC, the sponsor (the “Sponsor”) of Osprey Bitcoin Trust (the “Trust”), and CSC Delaware Trust Company, the trustee (the “Trustee”) of the Trust, entered into the Third Amended and Restated Declaration of Trust and Trust Agreement, dated as of December 18, 2025 ( the “Third Amended and Restated Trust Agreement”) to, among other things, revise, clarify and supplement (collectively, the “revisions”) provisions of the Trust Agreement to effectuate the conversion of the Trust into an exchange-traded product and the listing of the Trust’s units representing fractional undivided beneficial interests (the “Shares”) in its net assets on Nasdaq Stock Market LLC.”
Origin Materials, Inc. amended Amendment to Securities Purchase Agreement and Note with an institutional purchaser valued at up to $83.3 million (effective 2025-12-22).
“On December 22, 2025, Origin Materials, Inc. (the “Company”) entered into an Amendment to Securities Purchase Agreement and Note (the “Amendment”), amending that certain Securities Purchase Agreement, dated November 13, 2025, by and between the Company and an institutional purchaser, which provides for the issuance in tranches of senior secured convertible notes (the “Notes”). Among other things, the Amendment (i) requires the purchaser to purchase Notes in additional closings of up to $83.3 million in tranches of up to $25.0 million in aggregate principal amount of Notes at the Company’s request, subject to the satisfaction of certain conditions”
Wheels Up Experience Inc. entered into APA with UMB Bank, N.A., a national banking organization, not in its individual capacity but solely as owner trustee valued at approximately $104.7 million (effective 2025-12-22).
“On December 22, 2025, Wheels Up Partners LLC (“WUP LLC”), an indirect subsidiary of the Company, entered into an Aircraft Purchase Agreement with UMB Bank, N.A., a national banking organization, not in its individual capacity but solely as owner trustee (“Buyer” and such agreement, the “APA”), pursuant to which (i) WUP LLC expects to sell three (3) Bombardier Challenger 300 series and seven (7) Embraer Phenom 300 series aircraft (collectively, the “Leased Aircraft”) to Buyer (the “Sales”), and (ii) concurrently with such Sales, Wheels Up Private Jets LLC, an indirect subsidiary of the Company, expects to enter into long-term operating leases with Buyer for all 10 Leased Aircraft (together with the Sales, the “Transactions”).”
Aimco OP L.P. entered into Asset Purchase Agreement with HGI Acquisitions, LLC valued at sale of two properties for gross price of $155 million, non-refundable deposit of $5 million (effective 2025-12-23).
“On December 23, 2025, Apartment Investment and Management Company (“Aimco”), through Aimco Hillmeade, LLC and CCIP Plantation Gardens, L.L.C., each a subsidiary of Aimco, entered into an agreement (the “Agreement”) to sell two properties to HGI Acquisitions, LLC (the “buyer”) for a gross price of $155 million.”
Velo3D, Inc. entered into Purchase Agreement with certain institutional accredited investors (effective 2025-12-22).
“On December 22, 2025, Velo3D, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional accredited investors (the “Purchasers”), for the issuance and sale in a private placement of an aggregate of 3,636,363 shares of the Company’s common stock”
iPower Inc. entered into Securities Purchase Agreement with a certain institutional investor valued at $30,000,000 (effective 2025-12-22).
“On December 22, 2025, iPower Inc., a Nevada Company (the “Company”) entered into a Securities Purchase Agreement with a certain institutional investor (the “Investor”) named therein (the “Purchase Agreement”) providing for the purchase by the Investor of a 6% original issue discount (OID) convertible note facility in the aggregate original principal amount of $30,000,000”
HPS Corporate Lending Fund amended Eighth Amendment to Loan and Servicing Agreement with Morgan Stanley Bank, N.A. and Canadian Imperial Bank of Commerce, as lenders, and Morgan Stanley Senior Funding, Inc., as administrative agent valued at increases the Facility Amount to $1,600,000,000; extends Stated Maturity to December 23, 2030; exten (effective 2025-12-23).
“On December 23, 2025 (the “ Amendment Date ”), HPS Corporate Lending Fund (the “ Fund ”) entered into that certain Eighth Amendment to Loan and Servicing Agreement (the “ Amendment ”) with HLEND Holdings A, L.P., as borrower (the “ Borrower ”), Morgan Stanley Bank, N.A. and Canadian Imperial Bank of Commerce, as lenders, and Morgan Stanley Senior Funding, Inc., as administrative agent (the “ Agent ”), amending that certain Loan and Servicing Agreement, dated as of February 3, 2022, among the Fund, as the servicer, the Borrower, U.S. Bank Trust Company, National Association, as collateral agent, account bank and collateral custodian, the Agent, and the lenders from time to time party thereto (as amended and/or supplemented prior to the Amendment Date, the “ Credit Agreement ”).”
INTEGRAL AD SCIENCE HOLDING CORP. terminated Credit Agreement, dated as of September 29, 2021, as amended with PNC Bank, National Association, as administrative agent valued at Termination of Credit Agreement in connection with merger (effective 2025-12-23).
“Concurrently with the closing of the Merger, the Company (i) terminated that certain Credit Agreement, dated as of September 29, 2021, as amended, among Integral Ad Science, Inc., Kavacha Holdings, Inc., the other loan parties party thereto, the lenders party thereto and PNC Bank, National Association, as administrative agent, (ii) released all liens and security interests created and terminated all guarantees provided, in each case, in connection therewith and (iii) terminated all other obligations outstanding thereunder.”
Marpai, Inc. entered into Securities Purchase Agreement with certain investors valued at Expected gross proceeds of approximately $350,000; 350,000 shares of Class A common stock and warran (effective 2025-12-22).
“On December 22, 2025, Marpai Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain investors, pursuant to which the Company agreed to issue and sell an aggregate of: (i) 350,000 shares of its Class A common stock, par value $0.0001 per share (the “Common Stock”), and (ii) warrants (the “Common Warrants”) to purchase up to 700,000 shares of Common Stock in a private placement.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.